Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Conference Committee Disclosures: Dawn Koonkongsatian – Employee, Fresenius Medical Care Kristin Larson – Employee, NxStage Medical Denise Murcek – Employee, Fresenius Medical Care Beth St. John - Employee, Fresenius Medical Care Lucy Todd – Employee, Baxter Healthcare Kyra Trappett – Employee, DaVita
Commercial Support and Sponsorship: Supported by an unrestricted educational grant from Sanofi Renal.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Examine the pathophysiology of metabolic bone disease (MBD) and the importance of FGF-23 and klotho on MBD.
Discuss important research findings related to FGF-23 and Klotho and their impact on CKD patients.
Determine the changes necessary in policies and practices to improve the management of MBD based upon this new data.